---
title: 'Understanding Voriconazole Metabolism: A Middle-Out Physiologically-Based
  Pharmacokinetic Modelling Framework Integrating In Vitro and Clinical Insights'
date: '2024-10-30'
linkTitle: https://pubmed.ncbi.nlm.nih.gov/39476315/?utm_source=curl&utm_medium=rss&utm_campaign=pubmed-2&utm_content=1FakS-2QOkCT8HsMOQP1bCRQ4YzyumYOmxmF0moLsQ3dFB1E9V&fc=20220326224207&ff=20241030210344&v=2.18.0.post9+e462414
source: heidelberg[Affiliation]
description: 'CONCLUSION: This comprehensive parent-metabolite PBPK model of VRC quantitatively
  elucidated the complex metabolism of the drug and emphasised the substantial impact
  of the primary metabolites on VRC PK. The comprehensive approach combining bottom-up
  and middle-out modelling, thereby accounting for VRC autoinhibition, metabolite-mediated
  inhibition, and the impact of CYP2C19 genetic polymorphisms, enhances our understanding
  of VRC PK. Moreover, the model can be pivotal in designing further ...'
disable_comments: true
---
CONCLUSION: This comprehensive parent-metabolite PBPK model of VRC quantitatively elucidated the complex metabolism of the drug and emphasised the substantial impact of the primary metabolites on VRC PK. The comprehensive approach combining bottom-up and middle-out modelling, thereby accounting for VRC autoinhibition, metabolite-mediated inhibition, and the impact of CYP2C19 genetic polymorphisms, enhances our understanding of VRC PK. Moreover, the model can be pivotal in designing further ...